Aurobindo Pharma hits 52-week high despite 12% decline in PAT in Q4; here's why
In the January to March quarter this year, the company's revenues stood at ₹6,472.9 crore, up 11.4% as against ₹5,809.3 crore in the same period last year.
aurobindo pharma company
May 2023
November 2022
August 2022
November 2021
Aurobindo Pharma share hits a 52-week low. Here’s why
During the session, it tumbled 13.75% to hit an intraday low of ₹464. The market capitalisation of the pharmaceutical major declined to ₹28,037 crore.
Sensex, Nifty to rise as U.S. inflation cools; Eicher, CIL, Aurobindo Pharma, Bata shares eyed
The Sensex and Nifty are poised for a strong opening on upbeat global cues as a better-than-expected inflation report in the U.S. boosted investors’ appetite for riskier assets.
Competitors Within
Home-grown smaller players are giving biggies a run for their money in the US generics market.
